Drug Infusion Systems Market
完整報告名稱與涵蓋範圍
Drug Infusion Systems Market Size, Share & Trends Analysis Report By Product Type (Large Volume Infusion Systems, Patient Controlled Analgesia, Elastomeric Infusion Pumps and Others), By Application, By Region, And By Segment Forecasts, 2024-2031
報告摘要
The global Drug Infusion Systems Market is set to increase at a compound annual growth rate of 8.90% throughout the 2024–2031 forecast period.
Drug Infusion Systems covers a pump used to administer fluids, nutrients, or medications to a patient's circulatory system. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Several factors contribute to this trajectory, including heightened interest in next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, propelled by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Drug Infusion Systems Market Snapshot
Chapter 4. Global Drug Infusion Systems Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Dynamics - Drivers
4.3. Challenges/Restraints
4.4. Market Trends
4.5. Industry Analysis – Porter's Five Forces Analysis
4.6. Competitive Landscape & Market Share Analysis
4.7. COVID 19 Impact Analysis
Chapter 5. Market Segmentation 1: Product Type Estimates & Trend Analysis
5.1. Product Type & Market Share, 2018 & 2028
5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2018 to 2028 for the following Product Type:
5.2.1. Large Volume Infusion Systems
5.2.2. Patient Controlled Analgesia
5.2.3. Elastomeric Infusion Pumps
5.2.4. Insulin Infusion Pumps
5.2.5. Syringe Infusion Systems
5.2.6. Implantable Infusion Systems
5.2.7. Ambulatory Infusion Systems
5.2.8. Enteral Infusion Systems
Chapter 6. Drug Infusion Systems Market Segmentation 2: Application Estimates & Trend Analysis
6.1. Application Analysis & Market Share, 2019 & 2031
6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2019 to 2031 for the following Application:
6.2.1. Oncology/Chemotherapy
6.2.2. Diabetes
6.2.3. Analgesia
6.2.4. Nutrition
6.2.5. Haematology
6.2.6. Paediatrics
6.2.7. Other Applications
Chapter 7. Drug Infusion Systems Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2019-2031
7.1.2. North America Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2019-2031
7.1.3. North America Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2019-2031
7.1.3.1. U.S.
7.1.3.2. Canada
7.2. Europe
7.2.1. Europe Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2019-2031
7.2.2. Europe Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2019-2031
7.2.3. Europe Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) by country, 2019-2031
7.2.3.1. Germany
7.2.3.2. Poland
7.2.3.3. France
7.2.3.4. Italy
7.2.3.5. Spain
7.2.3.6. UK
7.2.3.7. Rest of Europe
7.3. Asia Pacific
7.3.1. Asia Pacific Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2019-2031
7.3.2. Asia Pacific Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2019-2031
7.3.3. Asia Pacific Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) by country, 2019-2031
7.3.3.1. China
7.3.3.2. India
7.3.3.3. Japan
7.3.3.4. Australia
7.3.3.5. Rest of Asia Pacific
7.4. Latin America
7.4.1. Latin America Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2019-2031
7.4.2. Latin America Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2019-2031
7.4.3. Latin America Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2019-2031
7.4.3.1. Brazil
7.4.3.2. Rest of Latin America
7.5. MEA
7.5.1. MEA Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2019-2031
7.5.2. MEA Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2019-2031
7.5.3. MEA revenue Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2019-2031
7.5.3.1. South Africa
7.5.3.2. Rest of MEA
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Acromed AG
8.2.2. B. Braun Melsungen AG
8.2.3. Baxter International Inc.
8.2.4. Becton, Dickinson and Company
8.2.5. Caesarea Medical Electronics Ltd.
8.2.6. Debiotech S.A.
8.2.7. Flowonix Medical Inc.
8.2.8. Fresenius SE & Co. KGaA
8.2.9. Halyard Health, Inc.
8.2.10. ICU Medical Inc.
8.2.11. IRADIMED CORPORATION
8.2.12. Insulet Corporation
8.2.13. Medtronic Public Limited Company
8.2.14. MOOG, Inc.
8.2.15. Smiths Group plc
8.2.16. Tandem Diabetes Care, Inc.
8.2.17. Terumo Corporation
8.2.18. Zyno Medical, LLC
8.3. List of Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們